Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bushen Huatan Decoction combined with Baduanjin for insulin-resistant polycystic ovary syndrome
ChiCTR2100043415Phase 4Recruiting
- Sponsor
- Zhangjiagang Hospital of Traditional Chinese Medicine
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of metformin and Bushen Huatan Decoction in polycystic ovary syndrome (PCOS) (5 arms), sponsored by Zhangjiagang Hospital of Traditional Chinese Medicine. Primary endpoints: HOMA-IR, OGTT and 1 more. Started Jan 2021; status: recruiting.
02
Drugs
metforminBushen Huatan Decoction
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on ChiCTR2100043415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043415.